Navigation Links
Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C.
Date:9/27/2011

WASHINGTON, Sept. 27, 2011 /PRNewswire/ -- More than 60 medical technology manufacturers from across the United States and around the globe will present their technologies at AdvaMed 2011: The MedTech Conference today.  Innovative device and diagnostic companies and academic tech transfer offices will make 9-minute company presentations to hundreds of industry business leaders, angel, private equity, and venture capital investors, and other strategic partners at the Walter E. Washington Convention Center in Washington, D.C.

Company presentations will be given in the following categories: blood, cardiology, health IT, imaging, In Vitro diagnostics, monitoring, neurological, orthopedics, pelvic health, sleep/monitoring, and wound management.  For more details on presenting companies visit, http://advamed2011.com/download/file/AVM2011_CoPresBookvFR.pdf. The competitively selected companies who will present at AdvaMed 2011 include:  

Allegro Diagnostics of Maynard, Massachusetts (www.allegrodx.com)

Alverix of San Jose, California (www.alverix.com)

Angel Medical Systems, Inc. of Shrewsbury, New Jersey (www.angel-med.com)

Austen BioInnovation Institute of Akron, Ohio (www.abiakron.org/)

BioBehavioral Diagnostics Co. of Westford, Massachusetts (www.biobdx.com)

BrainScope Company, Inc. of Bethesda, Maryland  (www.brainscope.com)

BREONICS of Albany, New York (www.breonics.com)  

B-TEMIA of Quebec, Canada (www.b-temia.com)

CD Diagnostics of Wynnewood, Pennsylvania (cddiagnostics.com)

Cervilenz Inc of Chagrin Falls, Ohio (www.cervilenz.com)

Claro Scientific, LLC of St. Petersburg, Florida (www.clarosci.com)

Cleankeys of Alberta, Canada (www.cleankeysinc.com)  

Clemson University Research Foundation (CURF) of Clemson, South Carolina (www.clemson.edu/curf)

ContourMed of Little Rock, Arkansas (www.contourmed.com)

CorInnova of Houston, Texas  (www.corinnova.com)

Creatv MicroTech, Inc. of Potomac, Maryland  (www.creatvmicrotech.com)

CytoSorbents of Monmouth Junction, New Jersey (www.cytosorbents.com)

DiFusion Technologies, Inc of Georgetown, Texas (www.difusiontech.com)

Discovery Labs of Warrington, Pennsylvania (www.discoverylabs.com)

Dymedix of Shoreview, Minnesota (www.dymedix.com)

ECI Biotech of Worcester, Massachusetts (www.ecibiotech.com)  

Exciton Technologies of Alberta, Canada (www.excitontech.com)

GlySure Ltd of Oxfordshire, United Kingdom (www.glysure.com

HPF GmbH of Gaggenau, Germany (www.hpf-medtech.de)  

Infrared Imaging Systems, Inc. of Marysville, Ohio (www.irimagesys.com)   

InfraScan, Inc. of Philadelphia, Pennsylvania (www.infrascanner.com)  

INRange Systems, Inc. of Altoona, Pennsylvania (www.inrangesystems.com)  

Insituvue of Pittsburgh, Pennsylvania (www.insituvue.com

Interface Biologics, Inc. of Toronto, Canada (www.interfacebiologics.com)

Leap Medical of Montreal, Canada (www.leapmedical.ca)  

LifeBond Ltd of Israel, (www.life-bond.com)

Lumora of Cambridgeshire, United Kingdom (www.lumora.co.uk)   

MedApps of Scottsdale, Arizona (www.medapps.com)  

Medi-Code of Katy, TX (www.medi-code.com)

MedMira of Halifax, Nova Scotia (www.medmira.com)

MedVoxel of British Columbia, Canada (www.medvoxel.com)

Monteris Medical, Inc. of Winnipeg, Canada & Kalamazoo, Michigan (www.monteris.com)

NeuroWave Systems Inc. of Cleveland Heights, Ohio (www.neurowavesystems.com)   

Novascan, LLC of Milwaukee, Wisconsin (www.novascan.com)

OJ Bio of Newcastle, United Kingdom  (www.oj-bio.com)

Pacific Edge of Dunedin, New Zealand (www.pacificedge.co.nz)

Precision Medical Devices, Inc. of Fort Lauderdale, Florida  (www.precisionmedicaldevices.com)

Pronia Medical Systems of Louisville, Kentucky (www.proniamed.com

Protomed of Marseille, France (www.protomed.fr)

P-Cure Ltd. of Yehuda, Israel (www.p-cure.com)

Regenesis Biomedical, Inc. of Scottsdale, Arizona (www.regenesisbio.com

RevDia Corp. of Hialeah, Florida (www.revdia.com)

RNA Diagnostics of Ontario, Canada (www.rnadiagnostics.com)

S14 IMPLANTS of Pessac, France (www.s14implants.com)  

SANOVAS Surgical Technologies of Sausalito, California (www.sanovas.com)

Segasist of Ontario, Canada (www.segasist.com)  

Semprus BioSciences of Cambridge, Massachusetts (www.semprusbio.com)  

Stealth of Beverly Hills, California (www.arnali.com)

STR Soft Tissue Regeneration, Inc. of New Haven, Connecticut (www.softtissueregeneration.com)

SuperNova Diagnostics, Inc. of Germantown, Maryland (www.supernovadiagnostics.com)  

Urovalve, Inc. of Newark, New Jersey (www.urovalve.com)

Vascular Magnetics, Inc. of Philadelphia, Pennsylvania (www.vascularmagnetics.com)  

VertiFlex of San Clemente, California (www.vertiflex.net)

VibeDX of Alberta, Canada (www.vibedx.com)

Wound Management Technologies of Fort Worth, Texas  (www.wmgtech.com)

Zephyr Technology of New Zealand (www.zephyr-technology.com)

In addition to the company presentations, AdvaMed 2011 will host two funding forums, 40 educational panels, a series of CEOs unplugged sessions, as well as Medtech partnering business development meetings, networking events, and sector meet-ups. To view the full conference program, visit www.AdvaMed2011.com


'/>"/>
SOURCE AdvaMed 2011
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
2. UPDATE: Total Victory for Schering-Plough (Now Merck) Pharmaceutical Reps in National Suit for Overtime Pay
3. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
4. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
5. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
6. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
7. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
8. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
9. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
10. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
11. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... NEW YORK , March 24, 2017 ... ... Research, a leading publisher of cannabis market research, the legal ... 27 percent CAGR through 2021, despite conflicting signals from the ... Analytics, points out that the two biggest drivers of growth ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... , ... According to the American Cancer Society , the average 15-year ... Once the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year ... this latter group, tune in to Lifestyle Magazine on April 9, 2017, ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently becoming ... require expert user knowledge. In a live webinar on April 11th and October ... highly accurate, determination of sodium. , It has long been known that too ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... entered a settlement agreement to resolve the pending litigation between itself and 1800 ... the District of Utah). , “I am thrilled to announce that we have ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 ... has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription opioids ...
(Date:3/27/2017)... HOUSTON, Texas (PRWEB) , ... March 27, 2017 , ... ... and hard of hearing, is bringing its latest products to the Deaf Seniors of ... attendees will have the opportunity to meet with knowledgeable ASL friendly staff from Harris ...
Breaking Medicine News(10 mins):